Insider Holders & Insider Ownership - REPLIGEN CORP (RGEN)

List of insiders holdings for REPLIGEN CORP:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1EDDLEMAN ROY T
10% Owner
2025-02-13 11:20:102,705,689
0
2,705,689Form 13G
2SCHIMMEL PAUL
Director
2007-06-18 17:01:47670,106
0
670,106Form 4
3Hunt Anthony
Director
2025-09-11 14:55:01283,087
0
283,087Form 4
4HERLIHY WALTER C
PRESIDENT, CEO
2015-05-14 12:45:14262,430
0
262,430Form 4
5Lieber Jonathan I
CFO
2013-03-12 09:31:28165,000
0
165,000Form 4
6MUEHL DANIEL W
CFO
2006-03-01 14:01:53120,000
0
120,000Form 4
7WITT DANIEL P
Senior Vice President
2014-06-24 09:38:52117,999
0
117,999Form 4
8Spurr Robert
Chief Commercial. Officer
2012-03-12 16:58:58110,000
0
110,000Form 3
9RICH ALEXANDER
Director
2011-12-19 16:18:26105,000
0
105,000Form 4
10Hall Michael
Chief Medical Officer
2012-03-12 16:53:39105,000
0
105,000Form 3
11Harris Timothy Scott
VP Corporate Development
2006-03-01 14:01:40100,000
0
100,000Form 4
12RUSCHE JAMES R
SENIOR VICE PRESIDENT
2017-02-14 19:45:2395,816
0
95,816Form 5
13DAWES KAREN A
Director
2025-05-19 15:27:2393,896
0
93,896Form 4
14COOPER GLENN L MD
Director
2019-06-19 19:04:1359,709
0
59,709Form 4/A
15Whitehouse Laura
Vice President
2007-05-29 15:57:2150,000
0
50,000Form 4
16Benjamin Howard
VP Business Development
2017-12-18 17:59:3345,042
0
45,042Form 4
17Loeillot Olivier
Chief Executive Officer
2025-10-06 10:59:4542,939
0
42,939Form 4
18Goldberg Alfred Lewis
Director
2015-05-26 18:28:3042,323
0
42,323Form 4
19Snodgres Jon
Chief Financial Officer
2023-05-16 19:00:4837,381
0
37,381Form 4
20MUIR GLENN P
Director
2025-05-19 20:19:0835,056
0
35,056Form 4
21Gebski Christine
See Remarks
2024-05-15 20:18:4427,419
0
27,419Form 4
22DAY BARBARA BURNIM
Former Vice President
2006-01-27 17:05:5624,500
0
24,500Form 4
23Bylund James
Chief Operating Officer
2025-04-02 10:33:4723,711
0
23,711Form 4
24Henry Earl Webb
Director
2013-05-16 14:13:5121,380
0
21,380Form 4
25KURIYEL RALF
Senior VP, R&D
2025-03-04 13:41:2320,604
0
20,604Form 4
26HENNESSEY ROBERT J
Director
2007-09-17 13:06:1920,000
0
20,000Form 4
27LANDY HAL
Vice President
2007-06-20 16:39:5420,000
0
20,000Form 4
28Kelly William J
Chief Accounting Officer
2014-03-03 13:00:5015,907
0
15,907Form 4
29Garland Jason K
CFO
2025-09-26 14:30:5413,383
0
13,383Form 4
30GRIFFITH MICHAEL A
Director
2014-11-12 15:08:269,932
0
9,932Form 4
31Hughes Violetta
CHIEF ACCOUNTING OFFICER
2025-09-04 12:47:448,056
0
8,056Form 4
32Madaus Martin D
Director
2025-08-12 12:47:075,586
1,811
7,397Form 4
33EGLINTON MANNER CARRIE
Director
2025-05-19 20:16:366,266
0
6,266Form 4
34BARTHELEMY NICOLAS
Director
2025-05-21 15:00:136,241
0
6,241Form 4
35Mhatre Rohin
Director
2025-05-19 14:38:035,819
0
5,819Form 4
36Konstantinov Konstantin
Director
2025-05-19 20:26:294,694
0
4,694Form 4
37Pax Margaret
Director
2025-05-19 14:59:343,816
0
3,816Form 4
38RYAN THOMAS F JR
Director
2022-03-02 21:14:081,457
0
1,457Form 4
39Cox John
Director
2020-03-26 19:31:58923
0
923Form 4
40BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
BVF INVESTMENTS LLC
LAMPERT MARK N
BVF INC
Indirect Beneficial Owner
10% Owner
2012-02-10 16:59:450
0
0Form 13G
41MILLER G WILLIAM
Director
2004-09-23 16:07:390
0
0Form 4